A non-canonical role for the C. elegans dosage compensation complex in growth and metabolic regulation downstream of TOR complex 2

Development (Cambridge)

Volumn 140, Issue 17, 2013, Pages 3601-3612

  Webster, Christopher M ^a,b   Wu, Lianfeng ^a,b   Douglas, Denzil ^a,b   Soukas, Alexander A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aging; C. elegans; Dosage compensation complex (DCC); dpy 21; Epigenetics; Growth; Metabolism; Rictor; Target of rapamycin (TOR); TOR complex 2 (TORC2)

Indexed keywords

DPY 21 PROTEIN; HISTONE H4; LYSINE; PROTEIN; RNA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TARGET OF RAPAMYCIN COMPLEX 2; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG; CHROMOSOME PROTEIN; METHYLTRANSFERASE; MUTANT PROTEIN; PROTEIN KINASE; SET 1 PROTEIN; SET 4 PROTEIN; TARGET OF RAPAMYCIN COMPLEX 2 SUBUNIT RICTOR;

ARTICLE; BODY SIZE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DISSECTION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC SCREENING; HISTONE METHYLATION; LIFESPAN; LIPID STORAGE; MALE; METABOLIC REGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; DOSAGE COMPENSATION COMPLEX; FAT MASS; FEMALE; GENE FUNCTION; GENE REPRESSION; GENE SEQUENCE; GROWTH RATE; GROWTH REGULATION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT;

AGING; C. ELEGANS; DOSAGE COMPENSATION COMPLEX (DCC); DPY-21; EPIGENETICS; GROWTH; METABOLISM; RICTOR; TARGET OF RAPAMYCIN (TOR); TOR COMPLEX 2 (TORC2);

ANIMALS; BLOTTING, WESTERN; BODY SIZE; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CARRIER PROTEINS; CLUTCH SIZE; DNA PRIMERS; DOSAGE COMPENSATION, GENETIC; ENERGY METABOLISM; EPIGENESIS, GENETIC; FEMALE; HISTONE-LYSINE N-METHYLTRANSFERASE; LONGEVITY; MALE; METHYLTRANSFERASES; MULTIPROTEIN COMPLEXES; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; TOR SERINE-THREONINE KINASES;

EID: 84883282987     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.094292     Document Type: Article

References (46)

1. Alessi, D. R., Pearce, L. R. and García-Martínez, J. M. (2009). New insights into mTOR signaling: mTORC2 and beyond. Sci. Signal. 2, pe27.
2. Aronova, S., Wedaman, K., Aronov, P. A., Fontes, K., Ramos, K., Hammock, B. D. and Powers, T. (2008). Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab. 7, 148-158.
3. Bhaskar, P. T. and Hay, N. (2007). The two TORCs and Akt. Dev. Cell 12, 487-502.
4. Bodenmiller, B., Campbell, D., Gerrits, B., Lam, H., Jovanovic, M., Picotti, P., Schlapbach, R. and Aebersold, R. (2008). PhosphoPep - a database of protein phosphorylation sites in model organisms. Nat. Biotechnol. 26, 1339-1340.
5. Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A. and Greenberg, M. E. (2001). Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21, 952-965.
6. Chuang, P. T., Albertson, D. G. and Meyer, B. J. (1994). DPY-27:a chromosome condensation protein homolog that regulates C. elegans dosage compensation through association with the X chromosome. Cell 79, 459-474.
7. Csankovszki, G., McDonel, P. and Meyer, B. J. (2004). Recruitment and spreading of the C. elegans dosage compensation complex along X chromosomes. Science 303, 1182-1185.
8. Dumas, K. J., Delaney, C. E., Flibotte, S., Moerman, D. G., Csankovszki, G. and Hu, P. J. (2013). Unexpected role for dosage compensation in the control of dauer arrest, insulin-like signaling, and FoxO transcription factor activity in Caenorhabditis elegans. Genetics 194, 619-629.
9. García-Martínez, J. M. and Alessi, D. R. (2008). mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem. J. 416, 375-385.
10. Gelbart, M. E. and Kuroda, M. I. (2009). Drosophila dosage compensation: a complex voyage to the X chromosome. Development 136, 1399-1410.
11. Grant, P. A. (2001). A tale of histone modifications. Genome Biol. 2, reviews0003-reviews0003.6.
12. Greer, E. L. and Brunet, A. (2008). FOXO transcription factors in ageing and cancer. Acta Physiol. (Oxf.) 192, 19-28.
13. Guertin, D. A. and Sabatini, D. M. (2007). Defining the role of mTOR in cancer. Cancer Cell 12, 9-22.
14. Guertin, D. A., Stevens, D. M., Saitoh, M., Kinkel, S., Crosby, K., Sheen, J. H., Mullholland, D. J., Magnuson, M. A., Wu, H. and Sabatini, D. M. (2009). mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15, 148-159.
15. Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F., Terracciano, L., Heim, M. H., Rüegg, M. A. and Hall, M. N. (2012). Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15, 725-738.
16. Hansen, M., Hsu, A. L., Dillin, A. and Kenyon, C. (2005). New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. PLoS Genet. 1, 119-128.
17. Helliwell, S. B., Wagner, P., Kunz, J., Deuter-Reinhard, M., Henriquez, R. and Hall, M. N. (1994). TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell 5, 105-118.
18. Hertweck, M., Göbel, C. and Baumeister, R. (2004). C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev. Cell 6, 577-588.
19. Hodgkin, J. (1987). Primary sex determination in the nematode C. elegans. Development 101 Suppl., 5-16.
20. Hsu, D. R. and Meyer, B. J. (1994). The dpy-30 gene encodes an essential component of the Caenorhabditis elegans dosage compensation machinery. Genetics 137, 999-1018.
21. Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. and Guan, K. L. (2008). Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919-1931.
22. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A. and Hall, M. N. (2004). Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128.
23. Jones, K. T., Greer, E. R., Pearce, D. and Ashrafi, K. (2009). Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol. 7, e60.
24. Kamada, Y., Fujioka, Y., Suzuki, N. N., Inagaki, F., Wullschleger, S., Loewith, R., Hall, M. N. and Ohsumi, Y. (2005). Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol. Cell. Biol. 25, 7239-7248.
25. Kamath, R. S. and Ahringer, J. (2003). Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30, 313-321.
26. Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S. et al. (2012). Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638-1643.
27. Lieb, J. D., Capowski, E. E., Meneely, P. and Meyer, B. J. (1996). DPY-26, a link between dosage compensation and meiotic chromosome segregation in the nematode. Science 274, 1732-1736.
28. Lyon, M. F. (1961). Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190, 372-373.
29. Meyer, B. J. (2005). X-Chromosome dosage compensation. In Wormbook, (ed. The C. elegans Research Community). doi/10.1895/wormbook.1.101.1: http://www.wormbook.org.
30. Meyer, B. J. and Casson, L. P. (1986). Caenorhabditis elegans compensates for the difference in X chromosome dosage between the sexes by regulating transcript levels. Cell 47, 871-881.
31. Nguyen, C. Q., Hall, D. H., Yang, Y. and Fitch, D. H. (1999). Morphogenesis of the Caenorhabditis elegans male tail tip. Dev. Biol. 207, 86-106.
32. Nishioka, K., Rice, J. C., Sarma, K., Erdjument-Bromage, H., Werner, J., Wang, Y., Chuikov, S., Valenzuela, P., Tempst, P., Steward, R. et al. (2002). PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol. Cell 9, 1201-1213.
33. Paradis, S. and Ruvkun, G. (1998). Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12, 2488-2498.
34. Pino, E. C., Webster, C. M., Carr, C. E. and Soukas, A. A. (2013). Biochemical and high throughput microscopic assessment of fat mass in Caenorhabditis elegans. J. Vis. Exp. 73, e50180.
35. Rice, J. C., Nishioka, K., Sarma, K., Steward, R., Reinberg, D. and Allis, C. D. (2002). Mitotic-specific methylation of histone H4 Lys 20 follows increased PR-Set7 expression and its localization to mitotic chromosomes. Genes Dev. 16, 2225-2230.
36. Robida-Stubbs, S., Glover-Cutter, K., Lamming, D. W., Mizunuma, M., Narasimhan, S. D., Neumann-Haefelin, E., Sabatini, D. M. and Blackwell, T. K. (2012). TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 15, 713-724.
37. Rohde, J. R. and Cardenas, M. E. (2003). The tor pathway regulates gene expression by linking nutrient sensing to histone acetylation. Mol. Cell. Biol. 23, 629-635.
38. Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
39. Schonbrun, M., Laor, D., López-Maury, L., Bähler, J., Kupiec, M. and Weisman, R. (2009). TOR complex 2 controls gene silencing, telomere length maintenance, and survival under DNA-damaging conditions. Mol. Cell. Biol. 29, 4584-4594.
40. Soukas, A. A., Kane, E. A., Carr, C. E., Melo, J. A. and Ruvkun, G. (2009). Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev. 23, 496-511.
41. Tsang, C. K., Bertram, P. G., Ai, W., Drenan, R. and Zheng, X. F. (2003). Chromatin-mediated regulation of nucleolar structure and RNA Pol I localization by TOR. EMBO J. 22, 6045-6056.
42. Tullet, J. M., Hertweck, M., An, J. H., Baker, J., Hwang, J. Y., Liu, S., Oliveira, R. P., Baumeister, R. and Blackwell, T. K. (2008). Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132, 1025-1038.
43. Vielle, A., Lang, J., Dong, Y., Ercan, S., Kotwaliwale, C., Rechtsteiner, A., Appert, A., Chen, Q. B., Dose, A., Egelhofer, T. et al. (2012). H4K20me1 contributes to downregulation of X-linked genes for C. elegans dosage compensation. PLoS Genet. 8, e1002933.
44. Wells, M. B., Snyder, M. J., Custer, L. M. and Csankovszki, G. (2012). Caenorhabditis elegans dosage compensation regulates histone H4 chromatin state on X chromosomes. Mol. Cell. Biol. 32, 1710-1719.
45. Yonker, S. A. and Meyer, B. J. (2003). Recruitment of C. elegans dosage compensation proteins for gene-specific versus chromosome-wide repression. Development 130, 6519-6532.
46. Yuan, M., Pino, E., Wu, L., Kacergis, M. and Soukas, A. A. (2012). Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J. Biol. Chem. 287, 29579-29588.